Macrophage-Derived Extracellular Vesicles: A Promising Tool for Personalized Cancer Therapy
The incidence of cancer is increasing dramatically, affecting all ages of the population and reaching an ever higher worldwide mortality rate. The lack of therapies’ efficacy is due to several factors such as a delay in diagnosis, tumor regrowth after surgical resection and the occurrence of multidr...
Main Authors: | Antonella Barone, Nicola d’Avanzo, Maria Chiara Cristiano, Donatella Paolino, Massimo Fresta |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/6/1252 |
Similar Items
-
Extracellular vesicles derived from macrophages: Current applications and prospects in tumors
by: Kecheng Lou, et al.
Published: (2022-12-01) -
Pharmacokinetics and biodistribution of extracellular vesicles administered intravenously and intranasally to Macaca nemestrina
by: Tom Driedonks, et al.
Published: (2022-10-01) -
Extracellular Vesicles as Drug Transporters
by: Monika Nowak, et al.
Published: (2023-06-01) -
Recent Progress in Extracellular Vesicle-Based Carriers for Targeted Drug Delivery in Cancer Therapy
by: Yaqin Tang, et al.
Published: (2023-07-01) -
Cancer Extracellular Vesicles: Next-Generation Diagnostic and Drug Delivery Nanotools
by: Stefano Palazzolo, et al.
Published: (2020-10-01)